In this study, it was observed that a 10 pg/mL decrease in plasma NT-proBNP during the first 2 years of intervention was associated with a 1% relative reduction in the primary composite outcome of CV death, MI, stroke, heart or leg revascularization procedures, and amputations [66]. This evidence concerns the gene NPPB and Stroke.